A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
BTG International Inc.
Gustave Roussy, Cancer Campus, Grand Paris
National Institute of Allergy and Infectious Diseases (NIAID)
SWOG Cancer Research Network
National Institute of Allergy and Infectious Diseases (NIAID)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
University of Miami
Progen Pharmaceuticals
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
University College, London
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
SWOG Cancer Research Network
M.D. Anderson Cancer Center
Northwestern University
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
NYU Langone Health
National Institutes of Health Clinical Center (CC)